Nicolas Barthelemy
CIK 1283576 · View on SEC EDGAR ↗
Insider
First SEC filing: Dec. 17, 2020 · Latest: Dec. 17, 2020
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 83 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
83 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 14, 2024 | RGEN | P | 1,200 | $125.45 | $150,540 | 4,668 Direct | +34.60% | Acquired | 32.7% (price as of 2026-08-18) |
| May 11, 2022 | TWST | P | 8,550 | $29.25 | $250,088 | 13,939 Direct | +158.66% | Acquired | 313.8% (price as of 2026-08-18) |
| Oct. 29, 2021 | RGEN | S | 360 | $288.19 | $103,748 | 1,547 Direct | -18.88% | Disposed | -42.3% (price as of 2026-08-18) |
| Oct. 29, 2021 | RGEN | S | 1,285 | $288.20 | $370,337 | 1,907 Direct | -40.26% | Disposed | -42.3% (price as of 2026-08-18) |
| June 24, 2021 | MASS | S 10b5-1 | 4,000 | $40.00 | $160,000 | 0 Direct | -100.00% | Disposed | -75.2% (price as of 2026-08-18) |
| June 23, 2021 | MASS | S 10b5-1 | 6,000 | $39.63 | $237,780 | 13,541 Indirect | -30.70% | Disposed | -74.9% (price as of 2026-08-18) |
| June 23, 2021 | MASS | S 10b5-1 | 3,000 | $39.53 | $118,590 | 0 Direct | -100.00% | Disposed | -74.9% (price as of 2026-08-18) |
| Feb. 9, 2021 | TWST | S | 5,000 | $177.61 | $888,050 | 1,898 Direct | -72.48% | Disposed | -31.9% (price as of 2026-08-18) |
| Dec. 22, 2020 | MASS | P | 14,000 | $20.00 | $280,000 | 14,000 Direct | — | Acquired | -50.4% (price as of 2026-08-18) |
| Nov. 9, 2020 | RGEN | S | 1,214 | $195.51 | $237,349 | 1,450 Direct | -45.57% | Disposed | -14.9% (price as of 2026-08-18) |
| May 18, 2020 | RGEN | S | 3,009 | $142.53 | $428,873 | 2,664 Direct | -53.04% | Disposed | 16.8% (price as of 2026-08-18) |
| April 22, 2020 | RGEN | S | 2,688 | $109.99 | $295,653 | 3,037 Direct | -46.95% | Disposed | 51.3% (price as of 2026-08-18) |
| April 3, 2020 | RGEN | S | 2,688 | $99.99 | $268,773 | 4,073 Direct | -39.76% | Disposed | 66.4% (price as of 2026-08-18) |
| Feb. 13, 2020 | LAB | P | 12,257 | $3.64 | $44,615 | 69,373 Indirect | +21.46% | Acquired | -81.1% (price as of 2026-08-18) |
| June 17, 2019 | LAB | S 10b5-1 | 5,100 | $12.43 | $63,393 | 41,849 Indirect | -10.86% | Disposed | -94.5% (price as of 2026-08-18) |
| Aug. 29, 2018 | RGEN | S | 6,580 | $54.44 | $358,215 | 4,186 Direct | -61.12% | Disposed | 205.7% (price as of 2026-08-18) |
| May 9, 2018 | RGEN | S | 26,500 | $40.54 | $1,074,310 | 4,854 Direct | -84.52% | Disposed | 310.5% (price as of 2026-08-18) |
Showing latest 100 of 116 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | RGEN | Stock Option (Right to Buy) | Common Stock (2,239) | $103.38 | May 14, 2036 | 2,239 | Acquired |
| May 15, 2025 | RGEN | Stock Option (Right to Buy) | Common Stock (1,800) | $123.26 | May 15, 2035 | 1,800 | Acquired |
| May 16, 2024 | RGEN | Stock Option (Right to Buy) | Common Stock (1,376) | $171.03 | May 16, 2034 | 1,376 | Acquired |
| May 18, 2023 | RGEN | Stock Option (Right to Buy) | Common Stock (1,487) | $156.63 | May 18, 2033 | 1,487 | Acquired |
| Nov. 21, 2022 | TWST | Director Stock Option (right to buy) | Common Stock (9,082) | $23.33 | Oct. 23, 2029 | 9,082 | Disposed |
| May 26, 2022 | RGEN | Stock Option (Right to Buy) | Common Stock (1,298) | $159.17 | May 26, 2032 | 1,298 | Acquired |
| April 1, 2022 | LAB | Stock Option (Right to Buy) | Common Stock (20,993) | $3.74 | June 23, 2030 | 20,993 | Disposed |
| March 31, 2022 | LAB | Stock Option (Right to Buy) | Common Stock (5,000) | $3.43 | Aug. 1, 2027 | 5,000 | Disposed |
| Oct. 29, 2021 | RGEN | Stock Option (Right to Buy) | Common Stock (1,285) | $128.18 | May 13, 2030 | 1,285 | Acquired |
| June 24, 2021 | MASS | Stock Option (option to buy) | Common Stock,par value $0.001 (46,167) | $1.58 | March 19, 2028 | 4,000 | Disposed |
| June 23, 2021 | MASS | Stock Option (option to buy) | Common Stock,par value $0.001 (49,167) | $1.58 | March 19, 2028 | 3,000 | Disposed |
| June 17, 2021 | MASS | Restricted Stock Unit | Common Stock, par value $0.001 (1,379) | — | — | 1,379 | Acquired |
| June 17, 2021 | MASS | Stock Option (option to buy) | Common Stock, par value $0.001 (2,455) | $41.70 | June 17, 2031 | 2,455 | Acquired |
| May 25, 2021 | LAB | Stock Option (Right to Buy) | Common Stock (15,402) | $5.56 | May 25, 2031 | 15,402 | Acquired |
| May 13, 2021 | RGEN | Stock Option (Right to Buy) | Common Stock (1,151) | $169.65 | May 13, 2031 | 1,151 | Acquired |
| March 23, 2021 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| Feb. 9, 2021 | TWST | Director Stock Option (right to buy) | Common Stock (5,000) | $23.33 | Oct. 23, 2029 | 5,000 | Disposed |
| Feb. 3, 2021 | TWST | Director Stock Option (right to buy) | Common Stock (973) | $189.96 | Feb. 2, 2031 | 973 | Acquired |
| Dec. 22, 2020 | MASS | Series E Preferred Stock | Common Stock, par value $0.001 (19,541) | — | — | 19,541 | Disposed |
| Dec. 17, 2020 | MASS | Stock Option (option to buy) | Common Stock, par value $0.001 (14,410) | $20.00 | — | 14,410 | Acquired |
| June 23, 2020 | LAB | Stock Option (Right to Buy) | Common Stock (20,993) | $3.74 | June 23, 2030 | 20,993 | Acquired |
| May 18, 2020 | RGEN | Stock Option (Right to Buy) | Common Stock (2,109) | $67.71 | May 15, 2029 | 2,109 | Acquired |
| May 13, 2020 | RGEN | Stock Option (Right to Buy) | Common Stock (1,285) | $128.18 | May 13, 2030 | 1,285 | Acquired |
| April 22, 2020 | RGEN | Stock Option (Right to Buy) | Common Stock (1,652) | $42.07 | May 16, 2028 | 1,652 | Disposed |
| April 3, 2020 | RGEN | Stock Option (Right to Buy) | Common Stock (1,652) | $42.07 | May 16, 2028 | 1,652 | Disposed |
| March 23, 2020 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| Feb. 4, 2020 | TWST | Director Stock Option (right to buy) | Common Stock | $26.20 | Feb. 3, 2030 | 11,297 | Acquired |
| Feb. 4, 2020 | TWST | Director Stock Option (right to buy) | Common Stock (5,648) | $26.20 | Feb. 3, 2030 | 5,648 | Acquired |
| Oct. 24, 2019 | TWST | Director Stock Option (right to buy) | Common Stock | $23.33 | Oct. 23, 2029 | 25,361 | Acquired |
| Oct. 24, 2019 | TWST | Director Stock Option (right to buy) | Common Stock (14,573) | $23.33 | Oct. 23, 2029 | 14,573 | Acquired |
| June 3, 2019 | LAB | Stock Option (Right to Buy) | Common Stock (6,796) | $13.41 | June 3, 2029 | 6,796 | Acquired |
| May 15, 2019 | RGEN | Stock Option (Right to Buy) | Common Stock (2,109) | $67.71 | May 15, 2029 | 2,109 | Acquired |
| March 23, 2019 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| Aug. 29, 2018 | RGEN | Stock Option (Right to Buy) | Common Stock (1,992) | $41.19 | May 21, 2025 | 1,992 | Disposed |
| Aug. 29, 2018 | RGEN | Stock Option (Right to Buy) | Common Stock (2,434) | $38.76 | May 18, 2027 | 2,434 | Disposed |
| May 31, 2018 | LAB | Stock Option (Right to Buy) | Common Stock (10,600) | $5.57 | May 31, 2028 | 10,600 | Acquired |
| May 30, 2018 | LAB | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Disposed |
| May 30, 2018 | LAB | Restricted Stock Units | Common Stock (5,000) | — | — | 5,000 | Disposed |
| May 16, 2018 | RGEN | Stock Option (Right to Buy) | Common Stock (3,304) | $42.07 | May 16, 2028 | 3,304 | Acquired |
| May 9, 2018 | RGEN | Stock Option (Right to Buy) | Common Stock (3,366) | $26.12 | May 11, 2026 | 3,366 | Disposed |
| May 9, 2018 | RGEN | Stock Option (Right to Buy) | Common Stock (24,000) | $20.37 | June 10, 2024 | 24,000 | Disposed |
| March 23, 2018 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| Dec. 31, 2017 | LAB | Restricted Stock Units | Common Stock (4,611) | — | — | 4,611 | Disposed |
| Sept. 30, 2017 | LAB | Restricted Stock Units | Common Stock (4,612) | — | — | 4,612 | Disposed |
| Sept. 13, 2017 | LAB | Stock Option (Right to Buy) | Common Stock (3,000) | $5.44 | Aug. 1, 2027 | 3,000 | Acquired |
| Sept. 13, 2017 | LAB | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Acquired |
| Aug. 8, 2017 | LAB | Restricted Stock Units | Common Stock (9,223) | — | — | 9,223 | Acquired |
| Aug. 1, 2017 | LAB | Stock Option (Right to Buy) | Common Stock (5,000) | $3.43 | Aug. 1, 2027 | 5,000 | Acquired |
| Aug. 1, 2017 | LAB | Restricted Stock Units | Common Stock (5,000) | — | — | 5,000 | Acquired |
| May 18, 2017 | RGEN | Stock Option (Right to Buy) | Common Stock (2,434) | $38.76 | May 18, 2027 | 2,434 | Acquired |
| March 23, 2017 | LAB | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $5.52 | March 23, 2027 | 15,000 | Acquired |
| March 23, 2017 | LAB | Restricted Stock Units | Common Stock (10,000) | — | — | 10,000 | Acquired |
| May 11, 2016 | RGEN | Stock Option (Right to Buy) | Common Stock (3,366) | $26.12 | May 11, 2026 | 3,366 | Acquired |
| May 21, 2015 | RGEN | Stock Option (Right to Buy) | Common Stock (1,992) | $41.19 | May 21, 2025 | 1,992 | Acquired |
| June 10, 2014 | RGEN | Stock Option (Right to Buy) | Common Stock (24,000) | $20.37 | June 10, 2024 | 24,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 17, 2020 | MASS | Stock Option (option to buy)→ Common Stock, par value $0.001 (49,167) | 49,167 | Direct |
| Dec. 17, 2020 | MASS | Stock Option (option to buy)→ Common Stock, par value $0.001 (24,583) | 24,583 | Direct |
| Dec. 17, 2020 | MASS | Series E Preferred Stock→ Common Stock, par value $0.001 (19,541) | 19,541 | Indirect |
| March 27, 2017 | LAB | Common Stock | 7,100 | Indirect |